Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.

69 patients (median age 53 years, 19-79 years old) with untreated acute non-lymphoblastic leukemia (ANLL) were randomized to receive either a regimen of amsacrine, cytarabine, thioguanine (AAT) or daunorubicin, cytarabine, thioguanine (DAT). AAT consisted of amsacrine 200 mg/m2/day x 5, thioguanine 100 mg/m2/12 h p.o.

[Group specific improvements in activities of daily living in elderly stroke patients in the rehabilitation phase. A report from the study, "Rehabilitation in geriatrics--analysis and evaluation of rehabilitation procedures in over-60 stroke patients with reference to its epidemiologic aspects")].

Significant as well as non-significant but still distinct improvements in the average functional status of Activities of Daily Living (ADL), according to the Barthel Index and Rüstigkeitsskala as shown by the total patient group of two rehabilitation clinics are presented. The initial status and the time elapsed between stroke and rehabilitation are of great importance for the changes which can be attained. Patient groups which differ in factors such as age, sex, and family status also show clear differences in the average improvement of their functional status.